Literature DB >> 25009989

Novel 5-arylcarbamoyl-2-methylisoxazolidin-3-yl-3-phosphonates as nucleotide analogues.

Kamil Kokosza1, Jan Balzarini, Dorota G Piotrowska.   

Abstract

A series of 5-substituted 3-phosphonylated isoxazolidines have been obtained via cycloaddition of N-methyl-C-(diethoxyphosphoryl)nitrone with N-heteroaromatic acrylamides. Good trans/cis diastereoselectivities (d.e. 58-76%) of isomeric (3-diethoxyphosphoryl)isoxazolidines were observed. cis- and trans-Isoxazolidine phosphonates were evaluated for their antiviral activity against a broad range of DNA and RNA viruses but were found inactive. Their cytostatic activity toward L1210, CEM, and HeLa cells was also established, and compounds cis-12r and trans-11r having a 2,2-difluorobenzo[d][1,3]dioxole moiety slightly inhibited proliferation of HeLa cells at IC50 values of 186 and 179 μM, respectively.

Entities:  

Keywords:  1,3-dipolar cycloaddition; Modified nucleosides; isoxazolidines; phosphonates

Mesh:

Substances:

Year:  2014        PMID: 25009989     DOI: 10.1080/15257770.2014.909046

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  3 in total

1.  Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.

Authors:  Carl C Ward; Jordan I Kleinman; Scott M Brittain; Patrick S Lee; Clive Yik Sham Chung; Kenneth Kim; Yana Petri; Jason R Thomas; John A Tallarico; Jeffrey M McKenna; Markus Schirle; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

2.  Harnessing the anti-cancer natural product nimbolide for targeted protein degradation.

Authors:  Jessica N Spradlin; Xirui Hu; Carl C Ward; Scott M Brittain; Michael D Jones; Lisha Ou; Milton To; Andrew Proudfoot; Elizabeth Ornelas; Mikias Woldegiorgis; James A Olzmann; Dirksen E Bussiere; Jason R Thomas; John A Tallarico; Jeffrey M McKenna; Markus Schirle; Thomas J Maimone; Daniel K Nomura
Journal:  Nat Chem Biol       Date:  2019-06-17       Impact factor: 15.040

3.  Design, antiviral and cytostatic properties of isoxazolidine-containing amonafide analogues.

Authors:  Kamil Kokosza; Graciela Andrei; Dominique Schols; Robert Snoeck; Dorota G Piotrowska
Journal:  Bioorg Med Chem       Date:  2015-05-06       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.